A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma
- PMID: 16729915
- DOI: 10.3816/CGC.2006.n.011
A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical